Annual Revenue
$157.75 M
-$48.01 M-23.33%
31 December 2023
Summary:
Arcturus Therapeutics Holdings annual revenue is currently $157.75 million, with the most recent change of -$48.01 million (-23.33%) on 31 December 2023. During the last 3 years, it has risen by +$148.21 million (+1553.72%). ARCT annual revenue is now -23.33% below its all-time high of $205.75 million, reached on 31 December 2022.ARCT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$38.81 M
-$7.16 M-15.58%
30 September 2024
Summary:
Arcturus Therapeutics Holdings quarterly revenue is currently $38.81 million, with the most recent change of -$7.16 million (-15.58%) on 30 September 2024. Over the past year, it has dropped by -$4.56 million (-10.52%). ARCT quarterly revenue is now -75.75% below its all-time high of $160.05 million, reached on 31 December 2022.ARCT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$142.47 M
-$4.56 M-3.10%
30 September 2024
Summary:
Arcturus Therapeutics Holdings TTM revenue is currently $142.47 million, with the most recent change of -$4.56 million (-3.10%) on 30 September 2024. Over the past year, it has dropped by -$150.25 million (-51.33%). ARCT TTM revenue is now -51.33% below its all-time high of $292.72 million, reached on 30 September 2023.ARCT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARCT Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -23.3% | -10.5% | -51.3% |
| 3 y3 years | +1553.7% | +1492.7% | +1518.4% |
| 5 y5 years | +901.4% | +1069.8% | +460.9% |
ARCT Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -23.3% | +1553.7% | -75.8% | +1492.7% | -51.3% | +1518.4% |
| 5 y | 5 years | -23.3% | +1553.7% | -75.8% | +1839.8% | -51.3% | +1537.7% |
| alltime | all time | -23.3% | +2470.0% | -75.8% | +1839.8% | -51.3% | +2221.1% |
Arcturus Therapeutics Holdings Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $38.81 M(-15.6%) | $142.47 M(-3.1%) |
| June 2024 | - | $45.98 M(+41.0%) | $147.03 M(+32.9%) |
| Mar 2024 | - | $32.60 M(+30.0%) | $110.62 M(-29.9%) |
| Dec 2023 | $157.75 M(-23.3%) | $25.08 M(-42.2%) | $157.75 M(-46.1%) |
| Sept 2023 | - | $43.38 M(+353.5%) | $292.72 M(+11.4%) |
| June 2023 | - | $9.56 M(-88.0%) | $262.71 M(-6.3%) |
| Mar 2023 | - | $79.73 M(-50.2%) | $280.24 M(+36.2%) |
| Dec 2022 | $205.75 M(+1564.8%) | $160.05 M(+1097.2%) | $205.75 M(+299.5%) |
| Sept 2022 | - | $13.37 M(-50.7%) | $51.50 M(+26.9%) |
| June 2022 | - | $27.09 M(+416.6%) | $40.57 M(+162.1%) |
| Mar 2022 | - | $5.24 M(-9.5%) | $15.48 M(+25.2%) |
| Dec 2021 | $12.36 M(+29.6%) | $5.79 M(+137.8%) | $12.36 M(+40.4%) |
| Sept 2021 | - | $2.44 M(+21.8%) | $8.80 M(+1.2%) |
| June 2021 | - | $2.00 M(-5.9%) | $8.70 M(-3.6%) |
| Mar 2021 | - | $2.13 M(-5.0%) | $9.02 M(-5.4%) |
| Dec 2020 | $9.54 M | $2.24 M(-4.1%) | $9.54 M(-7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $2.33 M(+0.5%) | $10.27 M(-8.8%) |
| June 2020 | - | $2.32 M(-12.2%) | $11.25 M(-41.0%) |
| Mar 2020 | - | $2.65 M(-10.8%) | $19.09 M(-8.2%) |
| Dec 2019 | $20.79 M(+32.0%) | $2.97 M(-10.5%) | $20.79 M(-18.1%) |
| Sept 2019 | - | $3.32 M(-67.3%) | $25.40 M(-0.4%) |
| June 2019 | - | $10.15 M(+133.4%) | $25.50 M(+43.8%) |
| Mar 2019 | - | $4.35 M(-42.6%) | $17.74 M(+12.6%) |
| Dec 2018 | $15.75 M(+21.2%) | $7.58 M(+121.4%) | $15.75 M(+54.5%) |
| Sept 2018 | - | $3.42 M(+43.5%) | $10.20 M(+1.3%) |
| June 2018 | - | $2.39 M(+0.8%) | $10.07 M(-12.0%) |
| Mar 2018 | - | $2.37 M(+17.2%) | $11.44 M(+26.1%) |
| Dec 2017 | $13.00 M(-36.2%) | $2.02 M(-38.7%) | $9.08 M(-66.9%) |
| Sept 2017 | - | $3.30 M(-12.4%) | $27.44 M(+13.7%) |
| June 2017 | - | $3.76 M(-81.5%) | $24.14 M(+18.5%) |
| Dec 2016 | $20.38 M(+232.1%) | $20.38 M(+232.1%) | $20.38 M(+232.1%) |
| Dec 2015 | $6.14 M | $6.14 M | $6.14 M |
FAQ
- What is Arcturus Therapeutics Holdings annual revenue?
- What is the all time high annual revenue for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual revenue year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly revenue?
- What is the all time high quarterly revenue for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly revenue year-on-year change?
- What is Arcturus Therapeutics Holdings TTM revenue?
- What is the all time high TTM revenue for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings TTM revenue year-on-year change?
What is Arcturus Therapeutics Holdings annual revenue?
The current annual revenue of ARCT is $157.75 M
What is the all time high annual revenue for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual revenue is $205.75 M
What is Arcturus Therapeutics Holdings annual revenue year-on-year change?
Over the past year, ARCT annual revenue has changed by -$48.01 M (-23.33%)
What is Arcturus Therapeutics Holdings quarterly revenue?
The current quarterly revenue of ARCT is $38.81 M
What is the all time high quarterly revenue for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly revenue is $160.05 M
What is Arcturus Therapeutics Holdings quarterly revenue year-on-year change?
Over the past year, ARCT quarterly revenue has changed by -$4.56 M (-10.52%)
What is Arcturus Therapeutics Holdings TTM revenue?
The current TTM revenue of ARCT is $142.47 M
What is the all time high TTM revenue for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high TTM revenue is $292.72 M
What is Arcturus Therapeutics Holdings TTM revenue year-on-year change?
Over the past year, ARCT TTM revenue has changed by -$150.25 M (-51.33%)